• Haoxi Health Technology entered a private placement with CEO and board chair Zhen Fan to sell 40,000,000 Class B ordinary shares at US$ 0.02 each, raising US$ 720,000.
• Pricing was set at about 101.12% of the May 18 closing price for the company’s Class A shares on Nasdaq.
• Proceeds are earmarked for working capital and general corporate purposes.
• The unregistered sale relies on exemptions under Section 4(a)(2) and/or Regulation S.
• Post-closing, Fan is expected to beneficially own 40,690,800 Class B shares, representing about 83.83% of total voting power; closing is expected around May 19.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-059033), on May 19, 2026, and is solely responsible for the information contained therein.